Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| carcinoma prostate |
|
Racial treatment trends in localized/regional prostate carcinoma brachytherapy (D), and combination therapy (E) stratified by race and ethnicity for white, Hispanic, and African-American patients with prostate carcinoma Enterolactone induces apoptosis in human prostate carcinoma LNCaP Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Li-Hua Chen1, Jing Fang1, The Journal of Urology : Primary Squamous cell Carcinoma of the 1 Squamous cell carcinoma of the prostate appears to be much more Microscopy of prostate tissue reveals well differentiated squamous cell carcinoma with Intraductal Carcinoma of the Prostate Gland With Transmucosal Intraductal Carcinoma of the Prostate Gland With Transmucosal Spread to the Seminal Vesicle: A Lesion Distinct From High-Grade Prostatic Intraepithelial Prostate The proportion of free to total prostate specific antigen: a method of detecting prostate carcinoma. Cancer. 1996;77:1137-1143. Prostate carcinoma incidence and patient mortality: the effects of BACKGROUND: Screening for and the aggressive treatment of prostate carcinoma are controversial, but they are nevertheless being practiced in the U.S. UroToday - Green Tea Polyphenol EGCG Sensitizes Human Prostate Green Tea Polyphenol EGCG Sensitizes Human Prostate Carcinoma LNCaP Cells to TRAIL-Mediated Apoptosis and Synergistically Inhibits Biomarkers Associated Definition: prostate carcinoma from Online Medical Dictionary stage A Tumour discovered incidentally in tissue removed for BPH, A1 Small focal involvement of one lobe, A2 Multifocal or diffuse carcinoma, MIR Teaching file case bs039 Prostate carcinoma. Images:. Anterior and posterior whole body delayed images. View main image(bs) in a separate viewing box. View second image(ct). Netter Medical Artwork - Carcinoma of Prostate II - Metastases Rights-managed illustration of Carcinoma of Prostate II - Metastases from the Netter Collection, drawn by Frank H. Netter. Cutaneous metastases from carcinoma of the prostate: A case report Brownstein and Helwig 6 find three cases of carcinoma of the prostate metastasizing to the skin. In 961 patients with prostate carcinoma, Held and Johnson eMedicine - Prostate Carcinoma : Article by Richard Clements Prostate cancer is an important growing health problem, presenting a challenge to urologists, radiologists, and oncologi. Prostate cancer - Wikipedia, the free encyclopedia Initially, small clumps of cancer cells remain confined to otherwise normal prostate glands, a condition known as carcinoma in situ or prostatic Prostatic Carcinoma - Patient UK Prostatic Carcinoma. Most prostate cancers are adenocarcinomas arising in the peripheral zone of the prostate gland. Prostate cancer is divided into: Gleason Grading Today, it is the most commonly used grading system for prostatic carcinoma worldwide. Multiple studies have confirmed that Gleason grade is a very powerful Nikon MicroscopyU: Human Pathology Digital Image Gallery Prostate carcinoma is second only to skin cancer as the most prevalent Prostate carcinoma is generally a very slow-growing type of cancer and most Prostate Cancer They are no longer law-abiding prostate cells serving the needs of the postate and the general good of the body. They are now outlaw carcinoma (cancer) prostate carcinoma a CHORUS notecard document about prostate carcinoma. Radiation Oncology | Full text | Squamous cell carcinoma of the Carcinoma of the prostate gland is the most frequent malignant tumour affecting male .. Baker WJ, Carney JF: Squamous cell carcinoma of prostate. |
| carcinoma prostate |
|
care prostate braky therapy prostate cancer benign dog hypertrophy in prostate cancer prostate video |